Investigating how Pitx2 helps the heart heal after injury.
The role of Pitx2 in heart injury and regeneration.
['FUNDING_R01'] · MEDICAL UNIVERSITY OF SOUTH CAROLINA · NIH-10813087
This study is looking at how a protein called Pitx2 helps the heart heal and recover after a heart attack, with the goal of finding better treatments to improve heart recovery and reduce scarring.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MEDICAL UNIVERSITY OF SOUTH CAROLINA (nih funded) |
| Locations | 1 site (CHARLESTON, UNITED STATES) |
| Trial ID | NIH-10813087 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the role of Pitx2, a specific protein, in the heart's response to injury and its ability to regenerate after a heart attack. The study will explore how Pitx2 influences cell survival and the formation of scar tissue in the heart, which is crucial for developing new therapies to improve heart recovery. By examining the effects of Pitx2 on heart cells and the surrounding environment, researchers aim to identify potential treatments that enhance healing and reduce harmful scarring. The research will involve laboratory experiments primarily using mouse models to test these hypotheses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a myocardial infarction or are at risk of heart injury.
Not a fit: Patients with non-cardiovascular conditions or those who have not experienced heart injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve heart healing and function after a heart attack.
How similar studies have performed: Previous research has shown promising results in using similar approaches to enhance heart regeneration, making this a potentially impactful area of study.
Where this research is happening
CHARLESTON, UNITED STATES
- MEDICAL UNIVERSITY OF SOUTH CAROLINA — CHARLESTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TAO, GE — MEDICAL UNIVERSITY OF SOUTH CAROLINA
- Study coordinator: TAO, GE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.